Key result
Percutaneous balloon valvotomy achieves 90% successful perforation in PA-IVS, enabling biventricular circulation in survivors.
Why the study?
Does percutaneous valve perforation and balloon dilation improve clinical outcomes and right heart morphology in patients with pulmonary atresia with intact ventricular septum?
Observational (n=30)
Does percutaneous valve perforation and balloon dilation improve clinical outcomes and right heart morphology in patients with pulmonary atresia with intact ventricular septum?
Percutaneous balloon valvotomy is an effective treatment strategy for PA-IVS that can maintain biventricular circulation in many patients, despite a lack of right heart catch-up growth.
Supports percutaneous valvotomy in selected PA-IVS cases; leaves open randomized data on right ventricular growth and long-term outcomes.
BACKGROUND: Pulmonary atresia with intact ventricular septum (PA-IVS) is a rare congenital lesion with high mortality. Therapy was exclusively surgical until recently, when the use of radiofrequency-assisted perforation of the atretic valve was introduced as a treatment option. This study analyzes the outcomes and morphological changes to right heart structures after percutaneous perforation and balloon dilation of the atretic valve. METHODS AND RESULTS: Between April 1992 and August 2000, 30 patients with PA-IVS underwent attempted percutaneous valve perforation and balloon dilation of the pulmonary valve. Longitudinal echocardiographic measurements of the tricuspid valve diameter, right ventricular length and area were recorded. Z scores were calculated according to published formulas. Perforation was achieved in 27 patients. In 14 patients a modified Blalock-Taussig shunt was performed between 2 and 24 days after valve dilation. There were 3 early and 2 late deaths. Among the survivors (follow-up time of 1 to 87 months), 16 patients had a biventricular circulation, 3 a 1(1/2)-ventricle circulation, and 1 a Fontan operation. Four patients are awaiting further palliation. There was no significant change of the tricuspid valve Z score or right ventricular length Z score with time. CONCLUSIONS: Percutaneous balloon valvotomy is an effective treatment strategy for patients with PA-IVS provided that there is a patent infundibulum and a lack of a right ventricle-dependent coronary circulation. Despite the observation that right heart growth does not increase with body growth in early follow-up, it appears adequate to maintain a biventricular circulation in many patients.
No takes yet. Share an insight, caveat, or question.
Humpl et al. (2003) conducted an observational in Pulmonary atresia with intact ventricular septum (PA-IVS) (n=30). Percutaneous valve perforation and balloon dilation was evaluated on Successful valve perforation. Percutaneous balloon valvotomy achieved successful perforation in 27 of 30 patients (90%) with PA-IVS, allowing 16 survivors to maintain a biventricular circulation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: